Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 1% phenytoin ointment around dental implants
IRCT20211124053173N2Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of phenytoin in Peri-implant soft tissue deficiency (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Average gingival height and Average gingival thickness. Started May 2024; status: completed.
02
Drugs
phenytoin
03
Conditions
Peri-implant soft tissue deficiency
Beyond the preview
Go deeper on IRCT20211124053173N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211124053173N2.